Studies have shown that CRIP3 is also closely related to tumorigenesis and can be used as a biomarker of epithelial tumors such as head and neck squamous cell carcinoma [72], lung squamous cell carcinoma [73], and prostate cancer [74], and constructed models can effectively predict the prognosis. This evidence concerns the gene CRIP3 and prostate cancer.